PharmaAQ Expert Forum – OOS/OOT Investigations – Overcoming Challenges
Overview
PAQ (Pharma Analysis and Quality) Expert Forum is a technical discussion group comprising of Senior Team Leaders and/or R & D Heads. The forum envisages bringing together both the Pharma companies at a single platform to discuss the hottest issues and topics for achieving research and business objectives. The objective of this PAQ Expert Forum is to discuss the bottlenecks and their solutions for conducting successful OOS/OOT investigations.
Out-of-Specification (OOS) and Out-of-Trend (OOT) results are the laboratory incidents or deviations resulting in unexpected results. Such deviations need to be clearly identified, explained and documented before the same is pointed out by a regulatory assessor. In pharmaceutical organizations OOS/OOT investigations are performed following standard protocols and checklists with the objective of finding the root cause of the deviation. Detailed investigations are done on the materials, chemicals, instruments procedures and personnel/analysts involved in the analysis to conclude the reason for OOS/OOT results.
Incorrectly documenting, improper investigation, incorrectly explained root cause, faulty management of OOS/OOT results and improper CAPA (Corrective and Preventive Actions) have resulted in warning letters as well as serious implications in Pharma and CRO companies in past as well as recently. This PAQ Expert forum will deliberate on the topic of OOS/OOT Investigations, its challenges, solutions, case studies and best practices with respect to their identification, investigation, management as well as ways to minimize them. This discussion forum will be held on October 22, 2021, virtually. This is brought to you by the organizing team of Pharma Analysis and Quality conferences in Mumbai on 11-12 October, 2018 and Round-table meetings on Nitrosamine Impurities in December 2019 and February 2020.
The H2L Concept
The H2L or Honing to Lead is a novel concept and means honing or refining skills of the team leaders who have the responsibility to steer their team towards achieving the organizational goals. The H2L concept is about refining specifically the technical skills of the team leaders through higher level experts who have vast first-hand experience in the respective areas so that the leader gets an extremely focused conceptual insight into the problem area. This essentially involves bringing together the leaders who share a common platform with the Experts and where the Experts develop an atmosphere conducive to open discussion rather than a regular speaking-listening session.
Who Should Attend
Heads, Vice Presidents, Directors, Senior Managers, Team Leaders, Senior Scientists from Pharma and CRO Organizations working in various domains: Analytical Method Development, Quality control, Formulation Development, Regulatory Affairs, Quality Assurance, Data management/data integrity, and Pharma R&D.
Contacts
Technical Query: Ms. Pooja Sharma, M: 7696325050, Email: p.sharma@glostem.com
Participation Query: Ms. Swati Kanwar, M: 8289015050, Email: s.kanwar@glostem.com
Registration Support: Ms. Ankita Kanwar, M: 7696425050, Email: ankita@glostem.com
Conference Date
22-10-2021
Jane Weitzel's Biography
Jane Weitzel
Pharmaceutical Consultant
Independent Consultants
Dr Jane Weitzel has been working in analytical chemistry for over 40 years for pharmaceutical and mining companies. She is currently a consultant specialising in laboratory management systems, GMP testing, and ISO/IEC 17025. She is an auditor and an educator. Dr Jane has applied Quality Systems and statistical techniques, including the evaluation and use of measurement uncertainty, in a wide variety of technical and scientific businesses. Recently she accepted the role of contributing writer for the American Society for Quality Handbook on Metrology.
Dr Jane was elected to the United States Pharmacopeia Council of Experts and is chair of the 2020-2025 General Chapters–Measurement and Data Quality Expert Committee. She was a member of the USP 2015-2020 Statistics Expert Committee and past member of the USP Expert Panel on Method Validation. She has been Director of pharmaceutical Quality Control laboratories. She has experience with many different regulatory environments.
Vipul Dholakia's Biography
Vipul Dholakia
Former Senior Policy Advisor and Consumer Safety Officer
FDA
Dr Dholakia is a Pharmaceutical professional with progressive and diversified experience in FD&C Act, GMP regulations, compliance policies and procedures, FDA principles and practices, facility inspections, audits, Pre-approval inspection preparations, Form 483 and warning letter response review and evaluation, third party audits, and regulatory compliance. Experience with bulk pharmaceuticals (API), liquid oral, solid oral, nasal, and topical dosage forms, stability studies, quality control and quality assurance, laboratory equipment/instruments qualification, standard operating procedures, cleaning validation, process validation, production equipment qualification, change control, corrective & preventive actions, manufacturing process, data integrity, data review and analysis, OOS/deviation investigations and project management.
B M Rao's Biography
B M Rao
Vice President & Head – ASAT & CQC
Dr Reddys Laboratories
Dr. BM Rao possess a Ph.D. degree in Chemistry and has about 27 years of work experience in pharmaceutical Analytical R&D and Quality Control functions in reputed organizations includes Janssen (pharmaceutical companies of Johnson & Johnson, Novartis, Zydus Cadila, Nicholas Piramal, and Dr. Reddy’s. He has a sound practical knowledge and thorough understanding of “Data Integrity”, its importance in cGMP Analytical laboratories. He has exposure to various regulatory audits includes USFDA, EMEA, TGA, Health Canada etc. and also worked with reputed International consultants in QC remediation. He has about 75 scientific publications in reputed national and international journals and successfully guided seven part-time Ph.D. candidates.
During his professional career he has been recognized for his contributions at work and won awards including Chairman’s Excellence Award from Dr. Reddy’s Laboratories (Feb, 2018), “Standards of Leadership” from J&J at Janssen, Mumbai site (year 2010) and Best New Leader Award at SAI Life Sciences Limited (year 2013). He has extensively travelled to USA, Mexico, Europe, Germany, Belgium, Singapore, Brazil, and Malaysia and interacted with several big and emerging biotech pharmaceutical analytical & quality experts.
At present, Dr. BM Rao is working as Vice President and Head of Analytical Science & Technology (ASAT) & Corporate Quality control at Dr. Reddy’s Laboratories providing technical leadership to the Analytical method validations/transfers and Quality Control labs of APIs and Formulations.
Bhaskar Kolte's Biography
Bhaskar Kolte
Associate Director -ARD
Perrigo Laboratories India Pvt Ltd
Conference Agenda
- Identifying OOS & OOT Test Results and CQA Risk Assessment
- OOS Investigations-Critical Factors in Designing and Conducting
- Minimizing OOS/OOT Results in an Analytical Laboratory
- Handling OOS Reports and Regulatory Queries
Agenda Topics for OOS/OOT Investigations – Overcoming Challenges
-
Identifying OOS & OOT Test Results and CQA Risk Assessment
- Identification of OOS and OOT Results, Trend analysis, Risk assessment
-
OOS Investigations-Critical Factors in Designing and Conducting
- Identifying Root Cause, Conducting OOS/OOT investigations, Corrective actions
-
Minimizing OOS/OOT Results in an Analytical Laboratory
- Analytical procedure robustness, Investigation process ruggedness, GLP/GDP
-
Handling OOS Reports and Regulatory Queries
- Critical components of OOS/OOT reports, Managing CAPA
Speakers & Panelists
Professor & Head,
NIPER Mohali,
Jane Weitzel's Biography
Jane Weitzel
Pharmaceutical Consultant
Independent Consultants
Dr Jane Weitzel has been working in analytical chemistry for over 40 years for pharmaceutical and mining companies. She is currently a consultant specialising in laboratory management systems, GMP testing, and ISO/IEC 17025. She is an auditor and an educator. Dr Jane has applied Quality Systems and statistical techniques, including the evaluation and use of measurement uncertainty, in a wide variety of technical and scientific businesses. Recently she accepted the role of contributing writer for the American Society for Quality Handbook on Metrology.
Dr Jane was elected to the United States Pharmacopeia Council of Experts and is chair of the 2020-2025 General Chapters–Measurement and Data Quality Expert Committee. She was a member of the USP 2015-2020 Statistics Expert Committee and past member of the USP Expert Panel on Method Validation. She has been Director of pharmaceutical Quality Control laboratories. She has experience with many different regulatory environments.
Pharmaceutical Consultant,
Independent Consultants,
Canada
Vipul Dholakia's Biography
Vipul Dholakia
Former Senior Policy Advisor and Consumer Safety Officer
FDA
Dr Dholakia is a Pharmaceutical professional with progressive and diversified experience in FD&C Act, GMP regulations, compliance policies and procedures, FDA principles and practices, facility inspections, audits, Pre-approval inspection preparations, Form 483 and warning letter response review and evaluation, third party audits, and regulatory compliance. Experience with bulk pharmaceuticals (API), liquid oral, solid oral, nasal, and topical dosage forms, stability studies, quality control and quality assurance, laboratory equipment/instruments qualification, standard operating procedures, cleaning validation, process validation, production equipment qualification, change control, corrective & preventive actions, manufacturing process, data integrity, data review and analysis, OOS/deviation investigations and project management.
Former Senior Policy Advisor and Consumer Safety Officer,
FDA,
USA
B M Rao's Biography
B M Rao
Vice President & Head – ASAT & CQC
Dr Reddys Laboratories
Dr. BM Rao possess a Ph.D. degree in Chemistry and has about 27 years of work experience in pharmaceutical Analytical R&D and Quality Control functions in reputed organizations includes Janssen (pharmaceutical companies of Johnson & Johnson, Novartis, Zydus Cadila, Nicholas Piramal, and Dr. Reddy’s. He has a sound practical knowledge and thorough understanding of “Data Integrity”, its importance in cGMP Analytical laboratories. He has exposure to various regulatory audits includes USFDA, EMEA, TGA, Health Canada etc. and also worked with reputed International consultants in QC remediation. He has about 75 scientific publications in reputed national and international journals and successfully guided seven part-time Ph.D. candidates.
During his professional career he has been recognized for his contributions at work and won awards including Chairman’s Excellence Award from Dr. Reddy’s Laboratories (Feb, 2018), “Standards of Leadership” from J&J at Janssen, Mumbai site (year 2010) and Best New Leader Award at SAI Life Sciences Limited (year 2013). He has extensively travelled to USA, Mexico, Europe, Germany, Belgium, Singapore, Brazil, and Malaysia and interacted with several big and emerging biotech pharmaceutical analytical & quality experts.
At present, Dr. BM Rao is working as Vice President and Head of Analytical Science & Technology (ASAT) & Corporate Quality control at Dr. Reddy’s Laboratories providing technical leadership to the Analytical method validations/transfers and Quality Control labs of APIs and Formulations.
Vice President & Head – ASAT & CQC,
Dr Reddys Laboratories,
Bhaskar Kolte's Biography
Bhaskar Kolte
Associate Director -ARD
Perrigo Laboratories India Pvt Ltd
Associate Director -ARD,
Perrigo Laboratories India Pvt Ltd,
OOS/OOT Investigations – Overcoming Challenges
Download Programme PDFFriday, 22nd October 2021
| 13:30 |
Test Run and Web Checks |
| 14:30 |
|
| 14:45 |
|
| 14:55 |
Identifying OOS & OOT Test Results and CQA Risk Assessment Vipul Dholakia, Former Senior Policy Advisor and Consumer Safety Officer, FDA, USA |
| 15:15 |
Open Discussion |
| 15:30 |
OOS Investigations-Critical Factors in Designing and Conducting BM Rao, Vice President, Dr Reddys Laboratories, India |
| 15:50 |
Open Discussion |
| 16:05 |
Minimizing OOS/OOT Results in an Analytical Laboratory Jane Weitzel, Pharmaceutical Consultant, Independent Consultants, Canada |
| 16:25 |
Open Discussion |
| 16:40 |
OOS/OOT Invesitgations - Overcoming Challenges: A Case Studies Bhaskar Kolte, Associate Director -ARD, Perrigo Laboratories India Pvt Ltd, |
| 17:00 |
Open Discussion/Rap Session |
| 17:25 |
Closing Remarks |
| 17:30 |
End of the meeting |